Annette North's Net Worth
$6.03 Million
Who is Annette North?
Annette North has an estimated net worth of $6.03 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., SGX PHARMACEUTICALS, INC., Kura Oncology, Inc., and AMBIT BIOSCIENCES CORP.
SEC CIK
Annette North's CIK is 0001341011
Past Insider Trading and Trends
2021 was Annette North's most active year for acquiring shares with 8 total transactions. Annette North's most active month to acquire stocks was the month of December. 2021 was Annette North's most active year for disposing of shares, totalling 25 transactions. Annette North's most active month to dispose stocks was the month of July. 2021 saw Annette North paying a total of $1,289,994.00 for 111,540 shares, this is the most they've acquired in one year. In 2021 Annette North cashed out on 145,882 shares for a total of $7,298,735.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
EVP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +126.28% | 15.61K |
$36.30 | -$24,284.70 | 27.98K |
Feb 9
| |||
Form 4
|
—
|
0
|
$48.50 | -$630,000.00 | 12.37K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
$47.02 | -$900,432.92 | 12.37K |
Scheduled
|
Jun 15
| ||
Form 4
| +90.73% | 5.88K |
$17.00 | $99,994.00 | 12.37K |
May 6
| |||
Form 4
|
—
|
0
|
$63.40 | -$1,855,939.48 | 6.48K |
Scheduled
|
Mar 8
| ||
Form 4
|
∞
| 6.48K |
—
|
—
| 6.48K |
Feb 8
| |||
Form 4
|
—
|
0
|
$71.44 | -$2,722,362.66 |
0
|
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SGX PHARMACEUTICALS, INC. No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kura Oncology, Inc. (KURA) Snapshot price: $19.29
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AMBIT BIOSCIENCES CORP No price found
Senior VP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |